Form 4: Arteris Inc. Insider Sells Shares Under 10b5-1 Plan

Arteris Inc. Chief Operating Officer Moll Laurent R reported the sale of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Moll Laurent R, Chief Operating Officer of Arteris, Inc., reported transactions involving the sale of company common stock.
• These sales were executed under a Rule 10b5-1 trading plan adopted on March 12, 2025.
• On April 10, 2026, 990 shares were sold at a price of $19.90 per share, resulting in a beneficial ownership of 279,982 shares.
• On April 13, 2026, an additional 1,003 shares were sold at a weighted average price of $19.90 (ranging from $19.90 to $19.91), reducing beneficial ownership to 278,979 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While insider selling can be a negative signal, the use of a 10b5-1 plan indicates a pre-determined strategy, mitigating concerns about opportunistic trading.

Negatives

• Insider selling activity, while often routine under 10b5-1 plans, can sometimes be perceived negatively by the market.
• The weighted average sale price indicates a slight downward pressure or a narrow trading range during the sale period.

Risks

• The sales were conducted under a 10b5-1 plan, which is designed to mitigate insider trading concerns, but the act of selling by a key executive could still be interpreted as a lack of confidence by some investors.
• The specific price range for the sales ($19.90-$19.91) might indicate a limited upward price movement or potential resistance at that level.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports past transactions.

Management Comments

• The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

StockSavvy.ai notes that Form 4 filings reporting sales under 10b5-1 plans are common for executives and are generally viewed as routine, designed to allow for planned stock sales without the appearance of trading on material non-public information. The specific price point of the sales may offer insight into the stock's trading range during that period.

Stakeholder Impact

• Shareholders: May interpret insider sales, even under a 10b5-1 plan, as a potential signal, though the plan itself is a governance mechanism to prevent insider trading.
• Management: The transactions reflect the executive's personal financial planning and diversification strategies.
• Regulatory Bodies (SEC): The filing ensures transparency and compliance with Section 16 of the Securities Exchange Act.

Next Steps

• The reporting person may continue to sell shares according to the 10b5-1 plan.
• The company may receive requests for further information regarding the specific sale prices from the SEC or security holders.

Key Dates

Keywords

Arteris Inc., Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Moll Laurent R, Chief Operating Officer, SEC Filing